» Articles » PMID: 35429618

Comparative Analysis of SARS-CoV-2 Quasispecies in the Upper and Lower Respiratory Tract Shows an Ongoing Evolution in the Spike Cleavage Site

Abstract

Studies are needed to better understand the genomic evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This study aimed to describe viral quasispecies population of upper and lower respiratory tract by next-generation sequencing in patients admitted to intensive care unit. A deep sequencing of the S gene of SARS-CoV-2 from 109 clinical specimens, sampled from the upper respiratory tract (URT) and lower respiratory tract (LRT) of 77 patients was performed. A higher incidence of non-synonymous mutations and indels was observed in the LRT among minority variants. This might be explained by the ability of the virus to invade cells without interacting with ACE2 (e.g. exploiting macrophage phagocytosis). Minority variants are highly concentrated around the gene portion encoding for the Spike cleavage site, with a higher incidence in the URT; four mutations are highly recurring among samples and were found associated with the URT. Interestingly, 55.8% of minority variants detected in this locus were T>G and G>T transversions. Results from this study evidenced the presence of selective pressure and suggest that an evolutionary process is still ongoing in one of the crucial sites of spike protein associated with the spillover to humans.

Citing Articles

"Outlaw" mutations in quasispecies of SARS-CoV-2 inhibit replication.

Colson P, Fantini J, Delerce J, Bader W, Levasseur A, Pontarotti P Emerg Microbes Infect. 2024; 13(1):2368211.

PMID: 38916498 PMC: 11207925. DOI: 10.1080/22221751.2024.2368211.


Real-life lack of evidence of viable SARS-CoV-2 transmission via inanimate surfaces: The SURFACE study.

Sammartino J, Colaneri M, Bassoli C, Ceresini M, Piralla A, Ferrari A J Infect Public Health. 2023; 16(5):736-740.

PMID: 36958168 PMC: 10027289. DOI: 10.1016/j.jiph.2023.03.016.


Comparative analysis of within-host diversity among vaccinated COVID-19 patients infected with different SARS-CoV-2 variants.

Al-Khatib H, Smatti M, Ali F, Zedan H, Thomas S, Ahmed M iScience. 2022; 25(11):105438.

PMID: 36310647 PMC: 9595287. DOI: 10.1016/j.isci.2022.105438.


Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients.

Franchini M, Focosi D, Percivalle E, Beccaria M, Garuti M, Arar O Viruses. 2022; 14(7).

PMID: 35891421 PMC: 9323140. DOI: 10.3390/v14071443.

References
1.
Bustin S, Benes V, Garson J, Hellemans J, Huggett J, Kubista M . The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009; 55(4):611-22. DOI: 10.1373/clinchem.2008.112797. View

2.
Long S, Olsen R, Christensen P, Bernard D, Davis J, Shukla M . Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area. mBio. 2020; 11(6). PMC: 7642679. DOI: 10.1128/mBio.02707-20. View

3.
Knyazev S, Tsyvina V, Shankar A, Melnyk A, Artyomenko A, Malygina T . Accurate assembly of minority viral haplotypes from next-generation sequencing through efficient noise reduction. Nucleic Acids Res. 2021; 49(17):e102. PMC: 8464054. DOI: 10.1093/nar/gkab576. View

4.
Dejnirattisai W, Huo J, Zhou D, Zahradnik J, Supasa P, Liu C . SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. Cell. 2022; 185(3):467-484.e15. PMC: 8723827. DOI: 10.1016/j.cell.2021.12.046. View

5.
Yusof W, Irekeola A, Wada Y, Engku Abd Rahman E, Ahmed N, Musa N . A Global Mutational Profile of SARS-CoV-2: A Systematic Review and Meta-Analysis of 368,316 COVID-19 Patients. Life (Basel). 2021; 11(11). PMC: 8620851. DOI: 10.3390/life11111224. View